The 2024 American Academy of Ophthalmology (AAO) Preferred Practice Patterns provide guidance for physicians about best practices in the treatment of age-related macular degeneration (AMD).

Like, say, Axon. Need a break? Play the USA TODAY Daily Crossword Puzzle. The Taser and police body cam company — furious that a group of Scottsdale citizens has temporarily halted its plan to ...

and eye imaging results to better understand the causes of dry age-related macular degeneration (dry AMD), a leading cause of vision loss. This approach led the biotech to the in-house discovery ...

Axon Enterprise, formerly known as Taser, went public in 2001. The police body camera and Taser manufacturer has split its stock three times. Its stock is up 80% over the past year. Before ...

SEOUL, South Korea--(BUSINESS WIRE)--Telechips (KOSDAQ: 054450) has introduced AXON (TCN100x), a high-performance network processor designed for mobility applications. AXON is a network System on ...

Here's what macular degeneration is, what causes it and how you can expect it to be treated if it affects you or a loved one. Macular degeneration, also known as age-related macular degeneration ...

While scientists have long known about axon degeneration, they haven’t had tools to stop it. Nura Bio’s lead drug candidate blocks a novel target associated with this damage to axons and the ...

A research team led by investigators at McMaster University has identified an axonal guidance signaling pathway that cancer cells use to infiltrate the brain. The combined results of preclinical ...

Share on Pinterest A formulation of over-the-counter antioxidant supplements may help prevent the progression of dry age-related macular degeneration, a new study finds. filmstudio/Getty Images ...

26, 27 This process is called Wallerian degeneration ... to neurotmesis. In this degree, there is nerve transection with complete loss of histological structures (axon, endoneurium, perineurium, and ...

Giant axonal neuropathy is a rare, autosomal recessive, pediatric, polysymptomatic, neurodegenerative disorder caused by biallelic loss-of-function variants in GAN, the gene encoding gigaxonin.